David Walk
Experienced in Short Stature (Growth Disorders)

Dr. David Walk

Neuromusculoskeletal Medicine
Northwestern Medical Group
259 E Erie St Ste 1900, Lavin Family Pavilion, 
Chicago, IL 
Offers Telehealth
42 Years of Experience

Experienced in Short Stature (Growth Disorders)
Northwestern Medical Group
259 E Erie St Ste 1900, Lavin Family Pavilion, 
Chicago, IL 
OverviewInsuranceLocationsClinical Research

Overview

David Walk is a Neuromusculoskeletal Medicine provider in Chicago, Illinois. Dr. Walk has been practicing medicine for over 42 years and is rated as an Experienced provider by MediFind in the treatment of Short Stature (Growth Disorders). His top areas of expertise are Cervical Myelopathy, Foot Drop, Secondary Adrenal Insufficiency, Short Stature (Growth Disorders), and Gastrostomy.

His clinical research consists of co-authoring 56 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Brown University Warren Alpert Medical School, 1984.0
Residency
University of Chicago
Specialties
Neuromusculoskeletal Medicine
Licenses
Psychiatry & Neurology in MN
Board Certifications
American Board Of Psychiatry And Neurology - Clinical Neurophysiology (Certified)
Hospital Affiliations
M Health Fairview University Of Mn
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
PreferredOne
  • HMO
  • OTHER COMMERCIAL
Primewest Health System
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VNS Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

259 E Erie St Ste 1900, Lavin Family Pavilion, Chicago, IL 60611
Call: 312-695-7950

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

A Phase 2b/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 12 Month Clinical Trial to Evaluate the Efficacy and Safety of MN-166 (Ibudilast) Followed by Open-Label Extension Phase in Subjects With Amyotrophic Lateral Sclerosis
A Phase 2b/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 12 Month Clinical Trial to Evaluate the Efficacy and Safety of MN-166 (Ibudilast) Followed by Open-Label Extension Phase in Subjects With Amyotrophic Lateral Sclerosis
Enrollment Status: Active_not_recruiting
Publish Date: September 16, 2025
Intervention Type: Drug
Study Drug: MN-166
Study Phase: Phase 2/Phase 3
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Enrollment Status: Enrolling_by_invitation
Publish Date: July 03, 2025
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
Enrollment Status: Active_not_recruiting
Publish Date: April 03, 2024
Intervention Type: Drug
Study Drug: (RS)-Baclofen, Naltrexone Hydrochloride and D-Sorbitol
Study Phase: Phase 3
A Pilot Study of Lung Volume Recruitment Combined With Expiratory Muscle Strength Training in ALS
A Pilot Study of Lung Volume Recruitment Combined With Expiratory Muscle Strength Training in ALS
Enrollment Status: Completed
Publish Date: February 23, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease Types 1 and X
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease Types 1 and X
Enrollment Status: Terminated
Publish Date: September 26, 2022
Intervention Type: Drug
Study Phase: Phase 2
Fluid Biomarkers With Deep Phenotyping in Patients With ALS
Fluid Biomarkers With Deep Phenotyping in Patients With ALS
Enrollment Status: Completed
Publish Date: December 16, 2021
Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)
Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)
Enrollment Status: Completed
Publish Date: February 18, 2021
Intervention Type: Drug
Study Phase: Phase 2
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Enrollment Status: Completed
Publish Date: July 06, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 7 Less Clinical Trials

56 Total Publications

Shared burden of ultra-rare genetic variants across a spectrum of motor neuron diseases.
Shared burden of ultra-rare genetic variants across a spectrum of motor neuron diseases.
Journal: Translational neurodegeneration
Published: August 11, 2025
View All 56 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Walk's expertise for a condition
ConditionClose
        • Experienced
        • Cervical Myelopathy
          Dr. Walk is
          Experienced
          . Learn about Cervical Myelopathy.
          See more Cervical Myelopathy experts
        • Foot Drop
          Dr. Walk is
          Experienced
          . Learn about Foot Drop.
          See more Foot Drop experts
        • Gastrostomy
          Dr. Walk is
          Experienced
          . Learn about Gastrostomy.
          See more Gastrostomy experts
        • Secondary Adrenal Insufficiency
          Dr. Walk is
          Experienced
          . Learn about Secondary Adrenal Insufficiency.
          See more Secondary Adrenal Insufficiency experts
        • Short Stature (Growth Disorders)
          Dr. Walk is
          Experienced
          . Learn about Short Stature (Growth Disorders).
          See more Short Stature (Growth Disorders) experts
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile
        For Patients
        • Our Story
        • How MediFind Works
        • Conditions A-Z
        • Doctor Directory
        • Symptoms Directory
        • Procedures Directory
        • Treatment Directory
        • Drug Directory
        • Infusion Center Finder
        • FAQ
        • Contact Us
        For Providers and Practices
        • Claim Your Profile
        • Newsroom
        Business Solutions
        • Provider
        • Network Solutions
        Additional Resources
        • Consumer Health Data Privacy Policy
        • Privacy Policy
        • Terms of Use
        • Advertising Policy
        • Content Policy
        Subscribe to our newsletter

        Sign up to stay informed about MediFind and get wellness sent your way.

        Close

          By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

          Bullet PinMediFind
          Follow us on
          This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
          © 2026 All Rights Reserved

          Request an Appointment

          If you are experiencing a medical emergency, call 9-1-1.

          MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

          Patient Details

          This information is for the patient who will be seen at the appointment.

            Close

            Returning patient? Use your address on file with the provider.

            Insurance Details

            Please provide information of the primary insurance holder as the practice may require this information to schedule.

            Insurance Provider *
            Insurance ProviderClose

            Appointments Details

            Let’s get more information about your appointment.

                    0 / 1000
                    0 / 1000
                    By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.